Relmada Therapeutics Inc (RLMD)
Relmada Therapeutics Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update
ORIGIN MATERIALS, INC. (ORGN)
Origin Announces HP Embalagens as Strategic Distributor for Sustainable PET Bottlecaps
NUCANA PLC (NCNA)
NuCana Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Business Update
RELMADA THERAPEUTICS, INC. (RLMD)
Relmada Therapeutics Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update
SAB BIOTHERAPEUTICS, INC. (SABS)
SAB BIO Announces Closing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants
SCHOLASTIC CORP (SCHL)
Scholastic Corporation Announces Intent to Repurchase Up to $200 Million of its Common Stock Through Modified Dutch Auction Tender Offer
SOLESENCE, INC. (SLSN)
Solésence To Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 31, 2026
FVCBANKCORP, INC. (FVCB)
FVCBankcorp Announces Extension of Share Repurchase Program
INHIBRX BIOSCIENCES, INC. (INBX)
Inhibrx Reports Fourth Quarter and Fiscal Year 2025 Financial Results
ACUMEN PHARMACEUTICALS, INC. (ABOS)
Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2025 Financial Results on March 26, 2026